Surgical Techniques for Crohn's Disease
(SPARES Trial)
Trial Summary
The trial allows participants to continue taking their current medications, including corticosteroids, 5-ASA drugs, thiopurines, MTX, antibiotics, anti-TNF, vedolizumab, and ustekinumab.
The research indicates that laparoscopic-assisted ileocolic resection for Crohn's disease is a safe and feasible procedure, although complications like mesenteric pseudoaneurysm can occur. Additionally, high ligation of arteries, while used in other conditions like rectal cancer, may affect blood flow, but this does not necessarily increase the risk of complications like anastomotic leakage.
12345The surgical technique, including high ligation of the ileocolic artery, is generally considered safe, but there are potential risks such as pseudoaneurysms (abnormal bulging of blood vessels) and ischemia (reduced blood flow) if arteries are mistakenly ligated. These complications are rare and can often be managed effectively with prompt treatment.
12678This treatment is unique because it involves high ligation (tying off) of the ileocolic artery and sparing the mesentery (the tissue that attaches the intestines to the abdominal wall), which is different from traditional surgeries that often remove diseased mesentery. This approach may help reduce postoperative recurrence of Crohn's disease.
29101112Eligibility Criteria
Adults aged 18-65 with Crohn's Disease affecting less than 30 cm of the terminal ileum and not responding to standard treatments can join. They must be able to follow the study protocol for 5 years and give consent. Excluded are those with a history of cancer, other significant medical conditions, or requiring additional surgeries beyond ileocolic resection.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo either a high ligation of ileocolic artery or mesenteric sparing ileocolic resection
Post-operative Monitoring
Participants are monitored for endoscopic recurrence using Rutgeerts score
Follow-up
Participants are monitored for clinical and surgical recurrence